Plants are a cost-effective, safe, and efficacious platform for large-scale production of vaccine in emerging economies. Key players in the market are focused on Research & Development (R&D) activities for development of plant-based vaccines for the treatment of infectious diseases. This is owing to the ability of plant-based vaccines to be mass produced, with higher efficiency, while maintaining lower cost compared to conventional vaccines. Plants as a vaccine source have the ability to generate complex recombinant proteins with desired structures, while maintaining biological functions and offering greater immune-specificity. Plants can be used as potential delivery system for oral vaccines.

Market Dynamics

Increasing geriatric population in Europe is another important factor for growth of the plant-based vaccine market in the region. According to the European Centre for Disease Prevention and Control’s (ECDC) - Seasonal influenza 2019-2020, Annual Epidemiological Report, nine countries in Europe reported nearly 10,705 laboratory-confirmed hospitalized influenza cases from 2019-2020 influenza season, among which 87% cases were due to influenza type A viruses.

Moreover, increasing prevalence of infectious diseases is expected to drive growth of the plant-based vaccines market. For instance, according to World Health Organization (WHO) December 2017 estimate, a seasonal influenza may result in 290,000- 650,000 deaths each year owing to respiratory diseases alone.  

Higher efficiency of plant-based vaccines over conventional vaccines and R&D activities and clinical trials for the development of plant-based vaccines are some of the factors expected to boost the growth of the market. Plant-based vaccines against HIV have gained significant traction of researchers, since AIDS has evolved as an alarming health problem, which is increasing economic burden of African countries and several emerging economies. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS); in 2017, Eastern Europe, Central Asia, the Middle East and North Africa accounted for 95% of new HIV infections. Easy production, oral administration of plant-based vaccines, and absence of purification needs offer great advantage in designing plant-based viral vaccines.

Key features of the study:

• This report provides an in-depth analysis of global plant-based vaccines market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global plant-based vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Medicago, Inc., IBIO, Inc., Icon Genetics GmbH, Lumen Bioscience, Inc., British American Tobacco Plc., Creative Biolabs, Inc., Leaf Expression Systems Ltd., ZYUS Life Sciences Inc., PlantForm Corporation, and Infectious Disease Research Institute (IDRI)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global plant-based vaccines market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the plant-based vaccines market

Detailed Segmentation:

• Global Plant-based Vaccines Market, By Vaccine Type:
  • Bacterial Vaccines
  • Viral Vaccines
  • Parasite Vaccines
  • Others
• Global Plant-based Vaccines Market, By Source:
  • Tobacco Plant
  • Maize
  • Potato
  • Others
• Global Plant-based Vaccines Market, By Application:
  • Influenza
  • Covid-19
  • Zika Virus
  • Ebola Virus
  • Poultry Disease
  • Others
• Global Plant-based Vaccines Market, By Region:
  • North America
    • By Vaccine Type:
      • Bacterial Vaccines
      • Viral Vaccines
      • Parasite Vaccines
      • Others
    • By Source:
      • Tobacco Plant
      • Maize
      • Potato
      • Others
    • By Application:
      • Influenza
      • Covid-19
      • Zika Virus
      • Ebola Virus
      • Poultry Disease
      • Others
    • By Country:
      • U.S.
      • Canada
      • Latin America
      • Introduction
      • Regional Trends
  • Europe
    • By Vaccine Type:
      • Bacterial Vaccines
      • Viral Vaccines
      • Parasite Vaccines
      • Others
    • By Source:
      • Tobacco Plant
      • Maize
      • Potato
      • Others
    • By Application:
      • Influenza
      • Covid-19
      • Zika Virus
      • Ebola Virus
      • Poultry Disease
      • Others
  • Asia Pacific
    • Introduction
    • Regional Trends
  • Middle East
    • Introduction
    • Regional Trends
  • Africa
    • Introduction
    • Regional Trends
• Company Profiles
  • Medicago, Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • IBIO, Inc.
  • Icon Genetics GmbH
  • Lumen Bioscience, Inc.
  • British American Tobacco Plc.
  • Creative Biolabs, Inc.
  • Leaf Expression Systems Ltd.
  • ZYUS Life Sciences Inc.
  • PlantForm Corporation
  • Infectious Disease Research Institute (IDRI)

“*” marked represents similar segmentation in other categories in the respective section.